0001156039-21-000050.txt : 20210526 0001156039-21-000050.hdr.sgml : 20210526 20210526163105 ACCESSION NUMBER: 0001156039-21-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210524 FILED AS OF DATE: 20210526 DATE AS OF CHANGE: 20210526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gallina John E CENTRAL INDEX KEY: 0001433032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 21966752 MAIL ADDRESS: STREET 1: 120 MONUMENT CIRCLE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anthem, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 3174886000 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 FORMER COMPANY: FORMER CONFORMED NAME: ANTHEM INC DATE OF NAME CHANGE: 20010730 4 1 wf-form4_162206103641936.xml FORM 4 X0306 4 2021-05-24 0 0001156039 Anthem, Inc. ANTM 0001433032 Gallina John E 220 VIRGINIA AVENUE INDIANAPOLIS IN 46204 0 1 0 0 EVP & Chief Financial Officer Common Stock 2021-05-24 4 M 0 5775 146.93 A 60095 D Common Stock 2021-05-24 4 M 0 1962 131.80 A 62057 D Common Stock 2021-05-24 4 M 0 4038 132.51 A 66095 D Common Stock 2021-05-24 4 M 0 19908 166.97 A 86003 D Common Stock 2021-05-24 4 M 0 14761 232.04 A 100764 D Common Stock 2021-05-24 4 S 0 17819 393.56 D 82945 D Common Stock 2021-05-24 4 S 0 8163 394.62 D 74782 D Common Stock 2021-05-24 4 S 0 15262 395.67 D 59520 D Common Stock 2021-05-24 4 S 0 1100 396.50 D 58420 D Common Stock 2021-05-24 4 S 0 4100 397.91 D 54320 D Common Stock 2021-05-25 5 G 0 E 3301 0 D 51019 D Employee Stock Option (Right to Buy) 146.93 2021-05-24 4 M 0 5775 0 D 2025-03-02 Common Stock 5775.0 0 D Employee Stock Option (Right to Buy) 131.8 2021-05-24 4 M 0 1962 0 D 2026-03-01 Common Stock 1962.0 0 D Employee Stock Option (Right to Buy) 132.51 2021-05-24 4 M 0 4038 0 D 2026-06-01 Common Stock 4038.0 0 D Employee Stock Option (Right to Buy) 166.97 2021-05-24 4 M 0 19908 0 D 2027-03-01 Common Stock 19908.0 0 D Employee Stock Option (Right to Buy) 232.04 2021-05-24 4 M 0 14761 0 D 2028-03-01 Common Stock 14761.0 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 22, 2021. This transaction was executed in multiple trades at prices ranging from $393.17 to $394.16. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $394.18 to $395.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $395.23 to $396.17. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $396.23 to $396.56. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $397.50 to $398.39. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option represents a right to purchase a total of 5,775 shares and is exercisable in six semi-annual installments, with three installments of 962 shares each and three installments of 963 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted. The option represents a right to purchase a total of 5,883 shares and is exercisable in six semi-annual installments, with three installments of 980 shares each and three installments of 981 shares each beginning on September 1, 2016, which is the six-month anniversary of the date on which the option was granted. The option represents a right to purchase a total of 8,074 shares and is exercisable in six semi-annual installments, with two installments of 1,345 shares each and four installments of 1,346 shares each beginning on December 1, 2016, which is the six-month anniversary of the date on which the option was granted. The option represents a right to purchase a total of 19,908 shares and is exercisable in six semi-annual installments of 3,318 shares each beginning on September 1, 2017, which is the six-month anniversary of the date on which the option was granted. The option represents a right to purchase a total of 14,761 shares and is exercisable in six semi-annual installments, with five installments of 2,460 shares each and one installment of 2,461 shares beginning on September 1, 2018, which is the six-month anniversary of the date on which the option was granted. /s/ Kathleen S. Kiefer, Attorney in fact 2021-05-26